- Home
- SLS vs NMFC Comparison
SLS vs NMFC Comparison
Compare SLS & NMFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLS | NMFC |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 924.5M | 796.4M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | SLS | NMFC |
|---|---|---|
| Price | $9.34 | $8.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $10.00 | $8.63 |
| AVG Volume (30 Days) | ★ 8.7M | 486.0K |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 15.27% |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $110.98 | N/A |
| P/E Ratio | ★ N/A | $12.51 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.39 | $7.47 |
| 52 Week High | $9.24 | $11.04 |
Technical Indicators
Market Signals| Indicator | SLS | NMFC |
|---|---|---|
| Relative Strength Index (RSI) | 72.49 | 49.79 |
| Support Level | $3.72 | $7.95 |
| Resistance Level | N/A | $8.28 |
| Average True Range (ATR) | 0.87 | 0.15 |
| MACD | 0.24 | -0.01 |
| Stochastic Oscillator | 96.41 | 56.32 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About NMFC New Mountain Finance Corporation
New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.